The role of diffusion and perfusion weighted imaging in the differential diagnosis of cerebral tumors: A review and future perspectives Tumour charcterisation

Cancer Imaging

Volumn 14, Issue 1, 2014, Pages

  Svolos, Patricia ^a   Kousi, Evanthia ^a   Kapsalaki, Eftychia ^b   Theodorou, Kyriaki ^a   Fezoulidis, Ioannis ^b   Kappas, Constantin ^a   Tsougos, Ioannis ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

Brain tumors; Differential diagnosis; Diffusion tensor imaging; Diffusion weighted imaging; Dynamic susceptibility contrast imaging

Indexed keywords

ANISOTROPY; BLOOD BRAIN BARRIER; BRAIN ABSCESS; BRAIN BLOOD FLOW; BRAIN METASTASIS; BRAIN TUMOR; CALCULATION; CANCER GRADING; CONTRAST RADIOGRAPHY; DIAGNOSTIC VALUE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DYNAMIC SUSCEPTIBILITY CONTRAST IMAGING; ECHO PLANAR IMAGING; FRACTIONAL ANISOTROPY; GLIOBLASTOMA; GLIOMA; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; LYMPHOMA; MATHEMATICAL ANALYSIS; MEAN TRANSIT TIME; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE SCANNER; PERFUSION WEIGHTED IMAGING; PRIMARY CEREBRAL LYMPHOMA; REVIEW; TRACTOGRAPHY; WHITE MATTER; AGED; BLOOD VOLUME; BRAIN CIRCULATION; BRAIN NEOPLASMS; DIFFERENTIAL DIAGNOSIS; PATHOPHYSIOLOGY; PROCEDURES; SCINTIGRAPHY; SECONDARY;

CONTRAST MEDIUM;

AGED; BLOOD VOLUME; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; GLIOMA; HUMANS; MENINGIOMA; PERFUSION IMAGING;

EID: 84907842581     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1186/1470-7330-14-20     Document Type: Review

References (134)

1. Hakyemez B, Erdogan C, Gokalp G, Dusak A, Parlak M: Solitary metastases and high-grade gliomas: radiological differentiation by morphometric analysis and perfusion-weighted MRI. Clin Radiol 2010,65(1):15-20. 10.1016/j.crad.2009.09.005
2. Chang SC, Lai PH, Chen WL, Weng HH, Ho JT, Wang JS, Chang CY, Pan HB, Yang CF: Diffusion-weighted MRI features of brain abscess and cystic or necrotic brain tumors: comparison with conventional MRI. Clin Imaging 2002,26(4):227-236. 10.1016/S0899-7071(02)00436-9
3. Liu X, Tian W, Kolar B, Yeaney GA, Qiu X, Johnson MD, Ekholm S: MR diffusion tensor and perfusion-weighted imaging in preoperative grading of supratentorial nonenhancing gliomas. Neuro Oncol 2011,13(4):447-455. 10.1093/neuonc/noq197
4. De Belder FE, Oot AR, Van Hecke W, Venstermans C, Menovsky T, Van Marck V, Van Goethem J, Van den Hauwe L, Vandekerckhove M, Parizel PM: Diffusion tensor imaging provides an insight into the microstructure of meningiomas, high-grade gliomas, and peritumoral edema. J Comput Assist Tomogr 2012,36(5):577-582. 10.1097/RCT.0b013e318261e913
5. Hakyemez B, Yildirim N, Erdogan C, Kocaeli H, Korfali E, Parlak M: Meningiomas with conventional MRI findings resembling intraaxial tumors: can perfusion-weighted MRI be helpful in differentiation? Neuroradiology 2006,48(10):695-702. 10.1007/s00234-006-0115-y
6. Calli C, Kitis O, Yunten N, Yurtseven T, Islekel S, Akalin T: Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 2006,58(3):394-403. 10.1016/j.ejrad.2005.12.032
7. Kremer S, Grand S, Remy C, Esteve F, Lefournier V, Pasquier B, Hoffmann D, Benabid AL, Le Bas JF: Cerebral blood volume mapping by MR imaging in the initial evaluation of brain tumors. J Neuroradiol 2002,29(2):105-113.
8. Server A, Kulle B, Maehlen J, Josefsen R, Schellhorn T, Kumar T, Langberg CW, Nakstad PH: Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema. Acta Radiol 2009,50(6):682-689. 10.1080/02841850902933123
9. Lu S, Ahn D, Johnson G, Law M, Zagzag D, Grossman RI: Diffusion-tensor MR imaging of intracranial neoplasia and associated peritumoral edema: introduction of the tumor infiltration index. Radiology 2004,232(1):221-228. 10.1148/radiol.2321030653
10. Wang S, Kim S, Chawla S, Wolf RL, Knipp DE, Vossough A, O'Rourke DM, Judy KD, Poptani H, Melhem ER: Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2011,32(3):507-514. 10.3174/ajnr.A2333
11. Tsougos I, Svolos P, Kousi E, Fountas K, Theodorou K, Fezoulidis I, Kapsalaki E: Differentiation of glioblastoma multiforme from metastatic brain tumor using proton magnetic resonance spectroscopy, diffusion and perfusion metrics at 3 T. Cancer Imaging 2012, 12:423-436. 10.1102/1470-7330.2012.0038
12. Gillard J, Waldman A, Barker P: Clinical MR Neuroimaging: Diffusion, Perfusion, Spectroscopy. Cambridge: Cambridge University Press; 2005.
13. Price SJ: The role of advanced MR imaging in understanding brain tumour pathology. Br J Neurosurg 2007,21(6):562-575. 10.1080/02688690701700935
14. Stejskal EO, Tanner JE: Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J Chem Phys 1965, 42:288-292. 10.1063/1.1695690
15. Moritani T, Ekholm S, Westesson PL: Diffusion-Weighted MR Imaging of the Brain. 2nd edition. Springer; 2009.
16. Tanner JE: Transient diffusion in a system partitioned by permeable barriers. Application to NMR measurements with a pulsed field gradient. J Chem Physiol 1978, 69:1748-1754. 10.1063/1.436751
17. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M: MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986, 161:401-407.
18. Debnam JM, Schellingerhout D: Diffusion MR imaging of the brain in patients with cancer. Int J Mol Imaging 2011, 2011:714021.
19. Field AS, Alexander AL: Diffusion tensor imaging in cerebral tumor diagnosis and therapy. Top Magn Reson Imaging 2004,15(5):315-324. 10.1097/00002142-200410000-00004
20. Mukherjee P, Berman JI, Chung SW, Chung SW, Hess CP, Henry RG: Diffusion tensor MR imaging and fiber tractography: theoretic underpinnings. AJNR Am J Neuroradiol 2008,29(4):632-641. 10.3174/ajnr.A1051
21. Le Bihan D: Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 2003,4(6):469-480. 10.1038/nrn1119
22. Alexander AL, Hasan K, Kindlmann G, Parker DL, Tsuruda JS: A geometric analysis of diffusion tensor measurements of the human brain. Magn Reson Med 2000,44(2):283-291. 10.1002/1522-2594(200008)44:2<283::AID-MRM16>3.0.CO;2-V
23. Pajevic S, Pierpaoli C: Color schemes to represent the orientation of anisotropic tissues from diffusion tensor data: application to white matter fiber tract mapping of the human brain. Magn Reson Med 1999,42(3):526-540. 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.0.CO;2-J
24. Westin CF, Maier SE, Mamata H, Nabavi A, Jolesz FA, Kikinis R: Processing and visualization for diffusion tensor MRI. Med Image Anal 2002,6(2):93-108. 10.1016/S1361-8415(02)00053-1
25. Mori S, Crain BJ, Chacko VP, van Zijl PC: Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol 1999,45(2):265-269. 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3
26. Jones DK, Simmons A, Williams SC, Horsfield MA: Non-invasive assessment of axonal fiber connectivity in the human brain via diffusion tensor MRI. Magn Reson Med 1999,42(1):37-41. 10.1002/(SICI)1522-2594(199907)42:1<37::AID-MRM7>3.0.CO;2-O
27. Mori S, van Zijl PCM: Fiber tracking: principles and strategies: a technical review. NMR Biomed 2002, 15:468-480. 10.1002/nbm.781
28. Parker GJ, Stephan KE, Barker GJ, Rowe JB, MacManus DG, Wheeler-Kingshott CA, Ciccarelli O, Passingham RE, Spinks RL, Lemon RN, Turner R: Initial demonstration of in vivo tracing of axonal projections in the macaque brain and comparison with the human brain using diffusion tensor imaging and fast marching tractography. Neuroimage 2002,15(4):797-809. 10.1006/nimg.2001.0994
29. Wakana S, Jiang H, Nagae-Poetscher LM, van Zijl PC, Mori S: Fiber tract-based atlas of human white matter anatomy. Radiology 2004,230(1):77-87. 10.1148/radiol.2301021640
30. Jellison BJ, Field AS, Medow J, Lazar M, Salamat MS, Alexander AL: Diffusion tensor imaging of cerebral white matter: a pictorial review of physics, fiber tract anatomy, and tumor imaging patterns. AJNR Am J Neuroradiol 2004,25(3):356-369.
31. Mori S, Fredericksen K, van Zijl PC, Stieltjes B, Kraut MA, Solaiyappan M, Pomper MG: Brain white matter anatomy of tumor patients using diffusion tensor imaging. Ann Neurol 2002,51(3):377-380. 10.1002/ana.10137
32. Bello L, Castellano A, Fava E, Casaceli G, Riva M, Scotti G, Gaini SM, Falini A: Intraoperative use of diffusion tensor imaging fiber tractography and subcortical mapping for resection of gliomas: technical considerations. Neurosurg Focus 2010,28(2):E6. 10.3171/2009.12.FOCUS09240
33. Hasan KM, Parker DL, Alexander AL: Comparison of gradient encoding schemes for diffusion-tensor MRI. J Magn Reson Imaging 2001,13(5):769-780. 10.1002/jmri.1107
34. Jones DK: The effect of gradient sampling schemes on measures derived from diffusion tensor MRI: a Monte Carlo study. Magn Reson Med 2004,51(4):807-815. 10.1002/mrm.20033
35. Nucifora PG, Verma R, Lee SK, Melhem ER: Diffusion tensor MR imaging and tractography: exploring brain microstructure and connectivity. Radiology 2007,245(2):367-384. 10.1148/radiol.2452060445
36. Gupta A, Shah A, Young RJ, Holodny AI: Imaging of brain tumors: functional magnetic resonance imaging and diffusion tensor imaging. Neuroimaging Clin N Am 2010,20(3):379-400. 10.1016/j.nic.2010.04.004
37. McRobbie DW, Moore EA, Graves MJ, Prince MR: MRI: From picture to proton. Cambridge University Press; 2005.
38. Liao W, Liu Y, Wang X, Jiang X, Tang B, Fang J, Chen C, Hu Z: Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging. Acta Radiol 2009,50(2):217-225. 10.1080/02841850802616752
39. Cha S: Perfusion MR imaging of brain tumors. Top Magn Reson Imaging 2004,15(5):279-289. 10.1097/00002142-200410000-00002
40. Donahue KM, Krouwer HG, Rand SD, Pathak AP, Marszalkowski CS, Censky SC, Prost RW: Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn Reson Med 2000,43(6):845-853. 10.1002/1522-2594(200006)43:6<845::AID-MRM10>3.0.CO;2-J
41. Boxerman JL, Schmainda KM, Weisskoff RM: Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006,27(4):859-867.
42. Watts JM, Whitlow CT, Maldjian JA: Clinical applications of arterial spin labeling. NMR Biomed 2013,26(8):892-900. 10.1002/nbm.2904
43. Batjer HH, Loftus CM: Textbook of neurological surgery. Lippincott, Williams & Wilkins; 2003:1257-1270. Ch. 102
44. Price SJ Advances and Technical Standards in Neurosurgery. In Advances in imaging low grade gliomas, Volume 35. Springer; 2010:1-34.
45. Fan GG, Deng QL, Wu ZH, Guo QY: Usefulness of diffusion/perfusion-weighted MRI in patients with non-enhancing supratentorial brain gliomas: a valuable tool to predict tumour grading? Br J Radiol 2006,79(944):652-658. 10.1259/bjr/25349497
46. Yamasaki F, Kurisu K, Satoh K, Arita K, Sugiyama K, Ohtaki M, Takaba J, Tominaga A, Hanaya R, Yoshioka H, Hama S, Ito Y, Kajiwara Y, Yahara K, Saito T, Thohar MA: Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology 2005,235(3):985-991. 10.1148/radiol.2353031338
47. Svolos P, Tsolaki E, Kapsalaki E, Theodorou K, Fountas K, Fezoulidis I, Tsougos I: Investigating brain tumor differentiation with diffusion and perfusion metrics at 3 T MRI using pattern recognition techniques. Magn Reson Imaging 2013,31(9):1567-1577. 10.1016/j.mri.2013.06.010
48. Zonari P, Baraldi P, Crisi G: Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging. Neuroradiology 2007,49(10):795-803. 10.1007/s00234-007-0253-x
49. Rizzo L, Crasto SG, Moruno PG, Cassoni P, Rudà R, Boccaletti R, Brosio M, De Lucchi R, Fava C: Role of diffusion- and perfusion-weighted MR imaging for brain tumour characterization. Radiol Med 2009,114(4):645-659. 10.1007/s11547-009-0401-y
50. Pauleit D, Langen KJ, Floeth F, Hautzel H, Riemenschneider MJ, Reifenberger G, Shah NJ, Müller HW: Can the apparent diffusion coefficient be used as a noninvasive parameter to distinguish tumor tissue from peritumoral tissue in cerebral gliomas? J Magn Reson Imaging 2004,20(5):758-764. 10.1002/jmri.20177
51. Lam WW, Poon WS, Metreweli C: Diffusion MR imaging in glioma: does it have any role in the pre-operation determination of grading of glioma? Clin Radiol 2002,57(3):219-225. 10.1053/crad.2001.0741
52. Kono K, Inoue Y, Nakayama K, Shakudo M, Morino M, Ohata K, Wakasa K, Yamada R: The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 2001,22(6):1081-1088.
53. Stadlbauer A, Ganslandt O, Buslei R, Hammen T, Gruber S, Moser E, Buchfelder M, Salomonowitz E, Nimsky C: Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging. Radiology 2006,240(3):803-810. 10.1148/radiol.2403050937
54. Tropine A, Vucurevic G, Delani P, Boor S, Hopf N, Bohl J, Stoeter P: Contribution of diffusion tensor imaging to delineation of gliomas and glioblastomas. J Magn Reson Imaging 2004,20(6):905-912. 10.1002/jmri.20217
55. Inoue T, Ogasawara K, Beppu T, Ogawa A, Kabasawa H: Diffusion tensor imaging for preoperative evaluation of tumor grade in gliomas. Clin Neurol Neurosurg 2005,107(3):174-180. 10.1016/j.clineuro.2004.06.011
56. Lee HY, Na DG, Song IC, Lee DH, Seo HS, Kim JH, Chang KH: Diffusion-tensor imaging for glioma grading at 3-T magnetic resonance imaging: analysis of fractional anisotropy and mean diffusivity. J Comput Assist Tomogr 2008,32(2):298-303. 10.1097/RCT.0b013e318076b44d
57. Beppu T, Inoue T, Shibata Y, Kurose A, Arai H, Ogasawara K, Ogawa A, Nakamura S, Kabasawa H: Measurement of fractional anisotropy using diffusion tensor MRI in supratentorial astrocytic tumors. J Neurooncol 2003,63(2):109-116. 10.1023/A:1023977520909
58. Goebell E, Paustenbach S, Vaeterlein O, Ding XQ, Heese O, Fiehler J, Kucinski T, Hagel C, Westphal M, Zeumer H: Low-grade and anaplastic gliomas: differences in architecture evaluated with diffusion-tensor MR imaging. Radiology 2006,239(1):217-222. 10.1148/radiol.2383050059
59. Chen Y, Shi Y, Song Z: Differences in the architecture of low-grade and high-grade gliomas evaluated using fiber density index and fractional anisotropy. J Clin Neurosci 2010,17(7):824-829. 10.1016/j.jocn.2009.11.022
60. Ferda J, Kastner J, Mukensnabl P, Choc M, Horemuzová J, Ferdová E, Kreuzberg B: Diffusion tensor magnetic resonance imaging of glial brain tumors. Eur J Radiol 2010,74(3):428-436. 10.1016/j.ejrad.2009.03.030
61. Hakyemez B, Erdogan C, Ercan I, Ergin N, Uysal S, Atahan S: High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Clin Radiol 2005,60(4):493-502. 10.1016/j.crad.2004.09.009
62. Senturk S, Oguz KK, Cila A: Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3 T MR scanner. Diagn Interv Radiol 2009,15(1):3-12.
63. Di Costanzo A, Pollice S, Trojsi F, Giannatempo GM, Popolizio T, Canalis L, Armillotta M, Maggialetti A, Carriero A, Tedeschi G, Scarabino T: Role of perfusion-weighted imaging at 3 Tesla in the assessment of malignancy of cerebral gliomas. Radiol Med 2008,113(1):134-143. 10.1007/s11547-008-0232-2
64. Preul C, Kuhn B, Lang EW, Mehdorn HM, Heller M, Link J: Differentiation of cerebral tumors using multi-section echo planar MR perfusion imaging. Eur J Radiol 2003,48(3):244-251. 10.1016/S0720-048X(03)00050-0
65. Law M, Yang S, Babb JS, Knopp EA, Golfinos JG, Zagzag D, Johnson G: Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004,25(5):746-755.
66. Cha S: Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 2006,27(3):475-487.
67. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D: Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002,223(1):11-29. 10.1148/radiol.2231010594
68. Lev MH, Ozsunar Y, Henson JW, Rasheed AA, Barest GD, Harsh GR 4th, Fitzek MM, Chiocca EA, Rabinov JD, Csavoy AN, Rosen BR, Hochberg FH, Schaefer PW, Gonzalez RG: Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR Am J Neuroradiol 2004,25(2):214-221.
69. Law M, Young RJ, Babb JS, Peccerelli N, Chheang S, Gruber ML, Miller DC, Golfinos JG, Zagzag D, Johnson G: Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2008,247(2):490-498. 10.1148/radiol.2472070898
70. Xu M, See SJ, Ng WH, Arul E, Back MF, Yeo TT, Lim CC: Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors. Neurosurgery 2005,56(5):919-926.
71. Cha S, Tihan T, Crawford F, Fischbein NJ, Chang S, Bollen A, Nelson SJ, Prados M, Berger MS, Dillon WP: Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2005,26(2):266-273.
72. Maia AC, Malheiros SM, da Rocha AJ, da Silva CJ, Gabbai AA, Ferraz FA, Stávale JN: MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. AJNR Am J Neuroradiol 2005,26(4):777-783.
73. Perry A, Louis DN, Scheithauer BW, Budka H, von Deimling A, et al.: Meningiomas. In WHO Classification of Tumours of the Central Nervous System. Edited by: Louis DN, Ohgaki H, Wiestler OD. Lyon: IARC Press; 2007:164-172.
74. Nagar VA, Ye JR, Ng WH, Chan YH, Hui F, Lee CK, Lim CC: Diffusion-weighted MR imaging: diagnosing atypical or malignant meningiomas and detecting tumor dedifferentiation. AJNR Am J Neuroradiol 2008,29(6):1147-1152. 10.3174/ajnr.A0996
75. Toh CH, Castillo M, Wong AM, Wei KC, Wong HF, Ng SH, Wan YL: Differentiation between classic and atypical meningiomas with use of diffusion tensor imaging. AJNR Am J Neuroradiol 2008,29(9):1630-1635. 10.3174/ajnr.A1170
76. Filippi CG, Edgar MA, Ulug AM, Prowda JC, Heier LA, Zimmerman RD: Appearance of meningiomas on diffusion-weighted images: correlating diffusion constants with histopathologic findings. AJNR Am J Neuroradiol 2001,22(1):65-72.
77. Buetow MP, Buetow PC, Smirniotopoulos JG: Typical, atypical, and misleading features in meningioma. Radiographics 1991,11(6):1087-1106. 10.1148/radiographics.11.6.1749851
78. Ellison D, Love S, Chimelli L, Harding BN, Lowe JS, Vinters HV, Brandner S, Yong WH: Meningiomas. In Neuropathology: A Reference Text of CNS Pathology. Edinburgh: Mosby; 2004:703-716.
79. Zhang H, Rodiger LA, Shen T, Miao J, Oudkerk M: Perfusion MR imaging for differentiation of benign and malignant meningiomas. Neuroradiology 2008,50(6):525-530. 10.1007/s00234-008-0373-y
80. Tropine A, Dellani PD, Glaser M, Bohl J, Plöner T, Vucurevic G, Perneczky A, Stoeter P: Differentiation of fibroblastic meningiomas from other benign subtypes using diffusion tensor imaging. J Magn Reson Imaging 2007,25(4):703-708. 10.1002/jmri.20887
81. Ginat DT, Mangla R, Yeaney G, Wang HZ: Correlation of diffusion and perfusion MRI with Ki-67 in high-grade meningiomas. AAm J Roentgenol 2010,195(6):1391-1395. 10.2214/AJR.10.4531
82. Santelli L, Ramondo G, Della Puppa A, Ermani M, Scienza R, d'Avella D, Manara R: Diffusion-weighted imaging does not predict histological grading in meningiomas. Acta Neurochir 2010,152(8):1315-1319. 10.1007/s00701-010-0657-y
83. Pavlisa G, Rados M, Pazanin L, Padovan RS, Ozretic D: Characteristics of typical and atypical meningiomas on ADC maps with respect to schwannomas. Clin Imaging 2008,32(1):22-27. 10.1016/j.clinimag.2007.07.007
84. Yang S, Law M, Zagzag D, Wu HH, Cha S, Golfinos JG, Knopp EA, Johnson G: Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomas. AJNR Am J Neuroradiol 2003,24(8):1554-1559.
85. Provenzale JM, McGraw P, Mhatre P, Guo AC, Delong D: Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging. Radiology 2004,232(2):451-460. 10.1148/radiol.2322030959
86. van Westen D, Latt J, Englund E, Brockstedt S, Larsson EM: Tumor extension in high-grade gliomas assessed with diffusion magnetic resonance imaging: values and lesion-to-brain ratios of apparent diffusion coefficient and fractional anisotropy. Acta Radiol 2006,47(3):311-319. 10.1080/02841850500539058
87. Lui YW, Malhotra A, Farinhas JM, Dasari SB, Weidenheim K, Freeman K, LaSala PA: Dynamic perfusion MRI characteristics of dural metastases and meningiomas: a pilot study characterizing the first-pass wash-in phase beyond relative cerebral blood volume. AAm J Roentgenol 2011,196(4):886-890. 10.2214/AJR.10.5309
88. Toh CH, Wong AM, Wei KC, Ng SH, Wong HF, Wan YL: Peritumoral edema of meningiomas and metastatic brain tumors: differences in diffusion characteristics evaluated with diffusion-tensor MR imaging. Neuroradiology 2007,49(6):489-494. 10.1007/s00234-007-0214-4
89. Sawaya R: Considerations in the diagnosis and management of brain metastases. Oncology 2001,15(9):1144-1154.
90. Patchell RA: Brain metastases. Neurol Clin 1991,9(4):817-827.
91. Lee SK: Diffusion tensor and perfusion imaging of brain tumors in high-field MR imaging. Neuroimaging Clin N Am 2012,22(2):123-134. 10.1016/j.nic.2012.02.001
92. Chiang IC, Kuo YT, Lu CY, Yeung KW, Lin WC, Sheu FO, Liu GC: Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiology 2004,46(8):619-627.
93. Lehmann G, Saliou G, de Marco G, Monet P, Souraya SE, Bruniau A, Vallée JN, Ducreux D: Cerebral peritumoral oedema study: Does a single dynamic MR sequence assessing perfusion and permeability can help to differentiate glioblastoma from metastasis? Eur J Radiol 2012,81(3):522-527. 10.1016/j.ejrad.2011.01.076
94. Server A, Orheim TE, Graff BA, Josefsen R, Kumar T, Nakstad PH: Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis. Neuroradiology 2011,53(5):319-330. 10.1007/s00234-010-0740-3
95. Bertossi M, Virgintino D, Maiorano E, Occhiogrosso M, Roncali L: Ultrastructural and morphometric investigation of human brain capillaries in normal and peritumoral tissues. Ultrastruct Pathol 1997,21(1):41-49. 10.3109/01913129709023246
96. Cha S, Lupo JM, Chen MH, Lamborn KR, McDermott MW, Berger MS, Nelson SJ, Dillon WP: Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR Imaging. AJNR Am J Neuroradiol 2007, 28:1078-1084. 10.3174/ajnr.A0484
97. Pavlisa G, Rados M, Pavic L, Potocki K, Mayer D: The differences of water diffusion between brain tissue infiltrated by tumor and peritumoral vasogenic edema. Clin Imaging 2009,33(2):96-101. 10.1016/j.clinimag.2008.06.035
98. Wang S, Kim S, Chawla S, Wolf RL, Zhang WG, O'Rourke DM, Judy KD, Melhem ER, Poptani H: Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging. Neuroimage 2009,44(3):653-660. 10.1016/j.neuroimage.2008.09.027
99. Lee EJ, terBrugge K, Mikulis D, Choi DS, Bae JM, Lee SK, Moon SY: Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions. AAm J Roentgenol 2011,196(1):71-76. 10.2214/AJR.10.4752
100. Altman DA, Atkinson DS Jr, Brat DJ: Best cases from the AFIP: glioblastoma multiforme. Radiographics 2007,27(3):883-888. 10.1148/rg.273065138
101. Hakyemez B, Erdogan C, Bolca N, Yildirim N, Gokalp G, Parlak M: Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging. J Magn Reson Imaging 2006,24(4):817-824. 10.1002/jmri.20707
102. Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG: Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro Oncol 1999,1(1):14-25.
103. Go JL, Lee SC, Kim PE: Imaging of primary central nervous system lymphoma. Neurosurg Focus 2006,21(5):E4.
104. Bataille B, Delwail V, Menet E, Vandermarcq P, Ingrand P, Wager M, Guy G, Lapierre F: Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 2000,92(2):261-266. 10.3171/jns.2000.92.2.0261
105. Guo AC, Cummings TJ, Dash RC, Provenzale JM: Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 2002,224(1):177-183. 10.1148/radiol.2241010637
106. Toh CH, Castillo M, Wong AM, Ng SH, Wan YL: Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging. AJNR Am J Neuroradiol 2008,29(3):471-475. 10.3174/ajnr.A0872
107. Kinoshita M, Hashimoto N, Goto T, Kagawa N, Kishima H, Izumoto S, Tanaka H, Fujita N, Yoshimine T: Fractional anisotropy and tumor cell density of the tumor core show positive correlation in diffusion tensor magnetic resonance imaging of malignant brain tumors. Neuroimage 2008,43(1):29-35. 10.1016/j.neuroimage.2008.06.041
108. Stadnik TW, Chaskis C, Michotte A, Shabana WM, van Rompaey K, Luypaert R, Budinsky L, Jellus V, Osteaux M: Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings. AJNR Am J Neuroradiol 2001,22(5):969-976.
109. Rollin N, Guyotat J, Streichenberger N, Honnorat J, Tran Minh VA, Cotton F: Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors. Neuroradiology 2006,48(3):150-159. 10.1007/s00234-005-0030-7
110. Bendini M, Marton E, Feletti A, Rossi S, Curtolo S, Inches I, Ronzon M, Longatti P, Di Paola F: Primary and metastatic intraaxial brain tumors: prospective comparison of multivoxel 2D chemical-shift imaging (CSI) proton MR spectroscopy, perfusion MRI, and histopathological findings in a group of 159 patients. Acta Neurochir 2011,153(2):403-412. 10.1007/s00701-010-0833-0
111. Cho SK, Na DG, Ryoo JW, Roh HG, Moon CH, Byun HS, Kim JH: Perfusion MR imaging: clinical utility for the differential diagnosis of various brain tumors. Korean J Radiol 2002,3(3):171-179. 10.3348/kjr.2002.3.3.171
112. Hartmann M, Heiland S, Harting I, Tronnier VM, Sommer C, Ludwig R, Sartor K: Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci Lett 2003,338(2):119-122. 10.1016/S0304-3940(02)01367-8
113. Lee IH, Kim ST, Kim HJ, Kim KH, Jeon P, Byun HS: Analysis of perfusion weighted image of CNS lymphoma. Eur J Radiol 2010,76(1):48-51. 10.1016/j.ejrad.2009.05.013
114. Grigoriadis E, Gold WL: Pyogenic brain abscess caused by Streptococcus pneumoniae: case report and review. Clin Infect Dis 1997,25(5):1108-1112. 10.1086/516097
115. Chan JH, Tsui EY, Chau LF, Chow KY, Chan MS, Yuen MK, Chan TL, Cheng WK, Wong KP: Discrimination of an infected brain tumor from a cerebral abscess by combined MR perfusion and diffusion imaging. Comput Med Imaging Graph 2002,26(1):19-23. 10.1016/S0895-6111(01)00023-4
116. Guo AC, Provenzale JM, Cruz LC Jr, Petrella JR: Cerebral abscesses: investigation using apparent diffusion coefficient maps. Neuroradiology 2001,43(5):370-374. 10.1007/s002340000519
117. Hartmann M, Jansen O, Heiland S, Sommer C, Munkel K, Sartor K: Restricted diffusion within ring enhancement is not pathognomonic for brain abscess. AJNR Am J Neuroradiol 2001,22(9):1738-1742.
118. Lai PH, Ho JT, Chen WL, Hsu SS, Wang JS, Pan HB, Yang CF: Brain abscess and necrotic brain tumor: discrimination with proton MR spectroscopy and diffusion-weighted imaging. AJNR Am J Neuroradiol 2002,23(8):1369-1377.
119. Nadal-Desbarats L, Herlidou S, de Marco G, Gondry-Jouet C, Le Gars D, Deramond H, Idy-Peretti I: Differential MRI diagnosis between brain abscesses and necrotic or cystic brain tumors using the apparent diffusion coefficient and normalized diffusion-weighted images. Magn Reson Imaging 2003,21(6):645-650. 10.1016/S0730-725X(03)00084-5
120. Nath K, Agarwal M, Ramola M, Husain M, Prasad KN, Rathore RK, Pandey CM, Gupta RK: Role of diffusion tensor imaging metrics and in vivo proton magnetic resonance spectroscopy in the differential diagnosis of cystic intracranial mass lesions. Magn Reson Imaging 2009,27(2):198-206. 10.1016/j.mri.2008.06.006
121. Reiche W, Schuchardt V, Hagen T, Il'yasov KA, Billmann P, Weber J: Differential diagnosis of intracranial ring enhancing cystic mass lesions-role of diffusion-weighted imaging (DWI) and diffusion-tensor imaging (DTI). Clin Neurol Neurosurg 2010,112(3):218-225. 10.1016/j.clineuro.2009.11.016
122. Gupta RK, Hasan KM, Mishra AM, Jha D, Husain M, Prasad KN, Narayana PA: High fractional anisotropy in brain abscesses versus other cystic intracranial lesions. Am J Neuroradiol 2005,26(5):1107-1114.
123. Holmes TM, Petrella JR, Provenzale JM: Distinction between cerebral abscesses and high-grade neoplasms by dynamic susceptibility contrast perfusion MRI. AAm J Roentgenol 2004,183(5):1247-1252. 10.2214/ajr.183.5.1831247
124. Kousi E, Tsougos I, Fountas K, Theodorou K, Tsolaki E, Fezoulidis I, Kapsalaki E: Distinct peak at 3.8 ppm observed by 3 T MR spectroscopy in meningiomas, while nearly absent in high-grade gliomas and cerebral metastases. Mol Med Report 2012,5(4):1011-1018.
125. Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D: Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003,24(10):1989-1998.
126. Georgiadis P, Kostopoulos S, Cavouras D, Glotsos D, Kalatzis I, Sifaki K, Malamas M, Solomou E, Nikiforidis G: Quantitative combination of volumetric MR imaging and MR spectroscopy data for the discrimination of meningiomas from metastatic brain tumors by means of pattern recognition. Magn Reson Imaging 2011,29(4):525-535. 10.1016/j.mri.2010.11.006
127. Zacharaki EI, Kanas VG, Davatzikos C: Investigating machine learning techniques for MRI-based classification of brain neoplasms. Int J Comput Assist Radiol Surg 2011,6(6):821-828. 10.1007/s11548-011-0559-3
128. Devos A, Simonetti AW, van der Graaf M, Lukas L, Suykens JA, Vanhamme L, Buydens LM, Heerschap A, Van Huffel S: The use of multivariate MR imaging intensities versus metabolic data from MR spectroscopic imaging for brain tumour classification. J Magn Reson 2005,173(2):218-228. 10.1016/j.jmr.2004.12.007
129. Tsolaki E, Svolos P, Kousi E, Kapsalaki E, Fountas K, Theodorou K, Tsougos I: Automated differentiation of glioblastomas from intracranial metastases using 3T MR spectroscopic and perfusion data. Int J Comput Assist Radiol Surg 2013,8(5):751-761. 10.1007/s11548-012-0808-0
130. Hu X, Wong KK, Young GS, Guo L, Wong ST: Support vector machine multiparametric MRI identification of pseudoprogression from tumor recurrence in patients with resected glioblastoma. J Magn Reson Imaging 2011,33(2):296-305. 10.1002/jmri.22432
131. Verma R, Zacharaki EI, Ou Y, Cai H, Chawla S, Lee SK, Melhem ER, Wolf R, Davatzikos C: Multiparametric tissue characterization of brain neoplasms and their recurrence using pattern classification of MR images. Acad Radiol 2008,15(8):966-977. 10.1016/j.acra.2008.01.029
132. Zacharaki EI, Wang S, Chawla S, Soo Yoo D, Wolf R, Melhem ER, Davatzikos C: Classification of brain tumor type and grade using MRI texture and shape in a machine learning scheme. Magn Reson Med 2009,62(6):1609-1618. 10.1002/mrm.22147
133. Blanchet L, Krooshof PW, Postma GJ, Idema AJ, Goraj B, Heerschap A, Buydens LM: Discrimination between metastasis and glioblastoma multiforme based on morphometric analysis of MR images. AJNR Am J Neuroradiol 2011,32(1):67-73.
134. Zacharaki EI, Morita N, Bhatt P, O'Rourke DM, Melhem ER, Davatzikos C: Survival analysis of patients with high-grade gliomas based on data mining of imaging variables. AJNR Am J Neuroradiol 2012,33(6):1065-1071. 10.3174/ajnr.A2939